phase readout
saveNCT05645536: Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
ENROLLING_BY_INVITATIONupdated 1d ago
community read0 votes
Sponsor: Tolmar Inc.. Phase: PHASE3. Conditions: Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that